Avdhoot Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.00 M
About Avdhoot Pharma
Avdhoot Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 January 2019 (Six years and one month 16 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Dharmin Pandya and Jignesh Joshi serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320GJ2019PTC105981
- Company No.
105981
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2019
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Avdhoot Pharma Private Limited offer?
Avdhoot Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Common Disease Medicines, Pharmaceutical Syrup, Digestive System Drugs & Medicines, Antacid Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Injection.
Who are the key members and board of directors at Avdhoot Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmin Pandya  | Director | 09-Jan-2019 | Current |
| Jignesh Joshi | Director | 09-Jan-2019 | Current |
Financial Performance of Avdhoot Pharma.
Avdhoot Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Avdhoot Pharma?
Unlock access to Avdhoot Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Idbi Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2020 | Idbi Bank Limited | ₹1.00 M | Open |
How Many Employees Work at Avdhoot Pharma?
Unlock and access historical data on people associated with Avdhoot Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avdhoot Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avdhoot Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.